4//SEC Filing
NPS PHARMACEUTICALS INC 4
Accession 0001104659-14-080341
CIK 0000890465operating
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 3:29 PM ET
Size
13.3 KB
Accession
0001104659-14-080341
Insider Transaction Report
Form 4
Selisker Rachel R
Director
Transactions
- Sale
Common Stock
2014-11-11$29.50/sh−15,188$448,087→ 9,900 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.52, inclusive. The reporting person undertakes to provide to NPS Pharmaceuticals, Inc., any security holder of NPS Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000890465
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 3:29 PM ET
- Size
- 13.3 KB